T. Michael O'Shea, MD MPH
received his neonatal training at Duke University and is the Chief of the Neonatology Division. Dr. O'Shea has also earned an Masters in Public Health from the School of Public Health at the University of North Carolina at Chapel Hill. His research interests are in the epidemiology of neonatal diseases, particularly neonatal chronic lung disease and cerebral palsy. He is the principal investigator at Wake Forest for the Extremely Low Gestational Age Newborn (ELGAN) study and the current Heart Rate Variability (HERO) study.
Dr O’Shea is currently the acting Neonatal Medicine Fellowship Director.
Phone: (336) 716-4663
FAX: (336) 716-2525
Email: moshea@wfubmc.edu
Physcian Directory Web Page
Selected Publications
1. Antecedents of cerebral palsy in very low-birth weight infants.
O'Shea TM, Dammann O.
Clinics in Perinatology 2000 Jun;27(2):285-302.
2. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age.
O'Shea TM , Kothadia JM, Klinepeter KL, Goldstein DJ, Jackson BG, Weaver RG 3rd, Dillard RG.
Pediatrics. 1999 Jul;104(1 Pt 1):15-21.
3. Perinatal events and the risk of intraparenchymal echodensity in very-low-birthweight neonates.
O'Shea TM, Kothadia JM, Roberts DD, Dillard RG.
Paediatr Perinat Epidemiol 1998 Oct;12(4):408-21.
Click for Full Michael OShea Publication List with Pubmed links